Prevention of viral hepatitis (B and C) reassessed

Koen Van Herck1, A Vorsters, P Van Damme

  • 1Centre for the Evaluation of Vaccination, Vaccine & Infectious Disease Institute, University of Antwerp, Antwerp, Belgium. koen.vanherck@ua.ac.be

Insights

Hepatitis B and C are global health threats, with HBV vaccination crucial but underutilized. Hepatitis C prevention relies on safety measures and treatment, though a vaccine is not imminent.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis B and C infections are significant global health issues, causing over 500 million chronic cases worldwide.
  • Co-infection with hepatitis B virus (HBV) and hepatitis C virus (HCV) is common due to shared transmission routes, especially in endemic regions and among high-risk populations.
  • Distinct epidemiological and transmission characteristics influence prevention strategies for each virus.

Purpose of the Study:

  • To review the epidemiology, transmission, and prevention strategies for hepatitis B and C.
  • To highlight the successes and challenges in controlling these viral hepatitis infections.
  • To emphasize the need for increased attention and efforts towards hepatitis B control.

Main Methods:

  • Review of existing literature on hepatitis B and C epidemiology and prevention.
  • Analysis of global public health data related to viral hepatitis.
  • Comparison of prevention strategies and their effectiveness for HBV and HCV.

Main Results:

  • A safe and effective HBV vaccine exists, with universal vaccination as the primary control strategy, yet vaccine uptake remains a challenge.
  • Hepatitis C control has seen success through universal precautions, blood screening, and patient identification/counseling, despite the lack of an immediate vaccine.
  • Transmission of hepatitis C continues to rise among injecting drug users despite ongoing efforts.

Conclusions:

  • Eliminating acute and chronic hepatitis B requires increased vaccination efforts and greater public and policy attention.
  • While a hepatitis C vaccine is not expected soon, continued implementation of public health measures is vital for its control.
  • Addressing the rising transmission of hepatitis C, particularly in vulnerable populations like injecting drug users, remains a critical challenge.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Smallpox01:24

Smallpox

Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...